Skip to main content

Table 1 Correlations between ECT2 expression and clinic-pathological features of 120 breast cancer patients in immunohistochemistry chip (HBreD145Su01)

From: Increased expression of ECT2 predicts the poor prognosis of breast cancer patients

Variables

N

ECT2 expression

P value

< 8 (low expression)

 ≥ 8 (high expression)

Age

   

0.224a

 < Median(51)

57

28

29

 

 ≥ Median (51)

63

24

39

 

Tumor location

   

0.961a

 Left

58

25

33

 

 Right

62

27

35

 

Grade

   

0.073a

 Grade 1

25

16

9

 

 Grade 2

90

44

56

 

Stage

   

0.043a

 Stage I–II

75

37

38

 

 Stage III–IV

43

13

30

 

Subtype

   

0.0041a

 Luminal

89

46

43

 

 Her2 enriched

13

4

9

 

 Basal

18

2

16

 
  1. aPearson Chi-square test
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us